Skip to content
Slide thumbnailPurchase Now

2022

Toolkit

Oncology

Oncology Insights+
Strategic Marketing for Business Development Professionals

CRMS Data

20% OFF
Limited Time Offer

Perfect B2B Solution to Identify New Leads & Connect in Minutes.

  • Oncology ToolKit comprises of OmicsX Two Key Market Intelligence Reports on Oncology Drug Development, which covers 2350 Active Oncology Drug Development Companies, and a prebuild Social CRM System, indexing all oncology Business Leaders working in these 2350 companies.
  • This UNIQUE PLATFORM, helps to accelerate & acquire new business development effort in many ways.
  • .
  • SINGLE PLATFORM - Combining CRMS with Intelligence.
  • Reports Provides, Undisputed Largest Insights; required as Decisions Inputs.
  • Provides 360 Degree View - Opportunities Explored Vs Remaining.
  • TIME SAVER & RESOURCES MULTIPLIER.
  • For BD TEAMs its TIME for ACTION.

Acquire 20% New Business Leads - Your Profit Accelerator

01

identify new opportunities

TWO Oncology reports

360 Degree Insights on Drug Development

  • 2350 Active Cancer Drug Developers.
  • 4300+ Active Molecules in Development.
  • 1500+ Deals & Partnering Details.
  • Special coverage on CAR-T, Vaccines, ADCs, Monoclonal Antibodies, Oncolytic Viruses and Small molecule Kinase Inhibitors.
  • Emerging Technologies like Microbiome, CRISPER, Exosomes, RNAi etc., as Cancer treatment are covered.

Oncology Clinical Drug Developers - 2022

World's Largest Insights on Active Global 1150 Clinical Stage Oncology Drug Developers.
-----------------------------------------
Includes Insights on
 Companies | Technologies
Pipeline | Targets | Deals | Funding

Buy Now

Report provides an extensive coverage on Oncology Drug Development and includes World’s Largest Number of Active Clinical Stage Oncology Drug Developers. (1150 Companies Profiles)

1200 Pages provides, in-depth Analysis on

  • GLOBAL 1150 CLINICAL STAGE ONCOLOGY DRUG DEVELOPERS.
  • 3500+ CANCER TARGETING MOLECULES IN DEVELOPMENT.
  • EMERGING CANCER DRUG TARGETS & PROPERITORY TECHNOLOGIES.
  • ONCOLOGY FOCUSED DEALS & PARTNERING ACTIVITIES.
  • INDIVIDUAL COMPANY FUNDING STATUS

Report opens an immense opportunities to New Business Development.
Explore More

Show

FURTHER DETAILS ON
GLOBAL ONCOLOGY CLINICAL DRUG INTELLIGENCE - 2022

Single Source Solution to Reach-out and connect World’s Largest Number of Active Early Stage Oncology Drug Developers. (1200 Companies).

865 Pages Report contains in-depth Analysis on

  • 1200 ACTIVE COMPANIES PROFILE
  • 1400+ CANCER TARGETING MOLECULES IN DEVELOPMENT.
  • EMERGING CANCER DRUG TARGETS & PROPERITORY TECHNOLOGIES.
  • ONCOLOGY FOCUSED DEALS & PARTNERING ACTIVITIES.
  • INDIVIDUAL COMPANY FUNDING STATUS, and much more. 

Report opens an immense opportunities to New Business Development.
Explore More

Show

Oncology Preclinical Drug Intelligence - 2022

World's Largest Insights on Active Global 1200 PreClinical Stage Oncology Drug Developers
-----------------------------------------
Includes Insights on
 Companies | Technologies
Pipeline | Targets | Deals | Funding

Buy Now

FURTHER DETAILS ON
GLOBAL ONCOLOGY PRECLINICAL DRUG INTELLIGENCE - 2022

02

ENGAGE WITH LEADS

Social CRM SYSTEM

Don’t Manage Contacts…

Engage Them

Further details / sample data
first in class product

10,000+ Oncology Key Accounts Prebuilt Social CRMS with Intelligence

  • Unique Solution - Combining CRMS with Intelligence - All at SINGLE PLATFORM.
  • PRELOADED CRMS with SOCIAL PROFILES
  • Valid Data, with current positions and valid Email IDs.
  • DATA can also be MERGED with any CRMS including SALESFORCE & HUBSPOT
  • IDENTIFY & CONNECT with NEW LEADS in minutes.​
  • COMPLETE CUSTOMIZED SUPPORT, to further scale your needs.
Comparisons
Oncology ToolKit 2022
Other Intelligence Sources
Clinical Stage Oncology Drug Developers
1150 Active Clinical Stage Companies
(Companies with Active Pipeline are only Included)
600-800 Companies
(maybe mixed with non active/ diagnostic etc.)
Pre-Clinical Stage Oncology Drug Developers
1200 Active Preclinical Stage Companies
(Well Funded with clear defined early stage Pipeline)
400-600 Companies
(with many inactive and other domain companies)
Worldwide Coverage
34 Countries Included
(52% USA, 24% Europe, 20% Asia and 4% ROW)
Mainly United States and Europe Covered
Oncology Drugs in Development
4400+ Onco Targeting Drugs in Active Development
(2600+ Clinical Stage with NCT Number & 1800+ Preclinical Stage, with their Targets and mechanism of Action)
2000 – 2500 Onco Targeting Drugs
(mainly includes Clinical Stage molecules in development)
Bio-Partnering Details
1400+ Oncology Deals complete details.
(Complete coverage on Oncology focused Deals, Funding & Partnering Activities, since company’s incorporation)
Limited to Database / Resource Subscribed to.
(Also it may require mapping of events between two or more different resources and filtering Onco Linked Deals).
Single Step Connect
Over 10,000+ Key Decision Makers in 2010 Companies.
(Manually Created and Validated Oncology Key Accounts CRM System with valid emails, contact no. and Social accounts details.
No Customized Solution Available in Market
(Needs months of hard team work to prepare authentic business development tool.

LIMITED TIME OFFER

GET 20% OFF on Oncology Toolkit 2022

$8400 USD
Regular Price $10500 USD

Identify and Partner

Prior to others

Trusted by

Over 150+ Companies

PCI-LOGO-MASTER-Pharma-Services-logo
a
b
c
d
e
f
g
h